2021-06-28 19:12
BOC Sciences is fully capable and committed to providing one-stop proteolysis targeting molecular drug discovery based on chimeric (Protac®)

2021-06-28 19:11
Chimera-targeted protein degradant (Protac®) is a new therapy.

2021-06-28 19:10
Protac® (protein degradation targeted chimera) is a special protein degradation technology,

2021-06-28 19:10
As a leading service provider in drug discovery and research, BOC Sciences is fully capable and committed to providing one-stop Proteolysis Targeting Chimeric (PROTAC®).

2021-05-31 19:08
PROTA (Proteolysis Targeting Chimeria) is a special protein degradation technology. Protac® technology uses the ubiquitin proteasome pathway,

2021-05-31 19:07
As a recognized leader in the field of drug discovery and development, coupled with more than a decade of experience,

2021-05-31 19:06
As a leading service provider in drug discovery and research, BOC Sciences is fully capable and committed to providing one-stop proteolysis targeting molecular drug discovery based on chimeric (Protac®).

2021-05-31 19:05
As a recognized leader in the field of drug discovery and development, coupled with more than a decade of experience,

2021-05-19 09:25
Once the design and modification of ligands for target protein/E3 ligase and linker are initially proposed by our scientists, Creative Biolabs will be dedicated to peptide/compound synthesis to offer high-quality products. With extensive experience a
... дальше